Erlotinib Glenmark

Erlotinib Glenmark is an oral medication used to treat certain types of cancer. This medication is designed to target specific proteins involved in cancer cell growth, offering a targeted approach to cancer therapy.

Erlotinib Glenmark is primarily used in the treatment of non-small cell lung cancer and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR), which can help slow the growth and spread of cancer cells. Patients often wonder, 'What is Erlotinib used for?' This medication is part of a broader category of cancer treatments known as tyrosine kinase inhibitors.

Common effects of Erlotinib Glenmark may include skin rash, diarrhea, and fatigue. Some patients may also experience appetite loss and nausea. These effects can vary in severity and may not affect everyone who takes the medication.

Erlotinib Glenmark should be handled with care, as it is a potent medication. It is important to follow the advice of a healthcare professional regarding its use. Patients with certain medical conditions or allergies should inform their healthcare provider before starting this treatment.

Erlotinib Glenmark may interact with other medications, including those that are metabolized by the liver. It is advisable to discuss all current medications with a healthcare provider to avoid potential interactions. Additionally, certain foods and supplements may also affect how this medication works.